Victor A. Sandor
Impact in
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 22
- Myeloproliferative Neoplasms: Diagnosis and Treatment 22
- Hematology 12
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Susan E. Bates (7 shared papers)Robert W. Robey (3 shared papers)Richard Piekarz (2 shared papers)Susan Bakke (2 shared papers)Paolo A. Ascierto (3 shared papers)Reinhard Dummer (3 shared papers)Michael D. Pickard (3 shared papers)Caroline Dutriaux (2 shared papers)
- Journals
- Blood (14 papers)Journal of Clinical Oncology (4 papers)The Lancet Oncology (2 papers)New England Journal of Medicine (2 papers)The Lancet (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Victor A. Sandor
45 papers receiving 6.4k citations
Victor A. Sandor's Hit Papers
Peers
Comparison fields: 5 of 103
- Genetics 2.2k
- Hematology 1.5k
- Oncology 2.4k
- Rheumatology 708
- Molecular Biology 3.1k
Countries citing papers authored by Victor A. Sandor
This map shows the geographic impact of Victor A. Sandor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor A. Sandor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor A. Sandor more than expected).
Fields of papers citing papers by Victor A. Sandor
This network shows the impact of papers produced by Victor A. Sandor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor A. Sandor. The network helps show where Victor A. Sandor may publish in the future.
Co-authors
The 25 scholars most cited alongside Victor A. Sandor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis Hit paper breakdown → | 2012 | 1715 |
| 2 | Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer Hit paper breakdown → | 2019 | 1117 |
| 3 | Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial Hit paper breakdown → | 2018 | 813 |
| 4 | Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial Hit paper breakdown → | 2018 | 465 |
| 5 | Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. | 2002 | 463 |
| 6 | 2001 | 394 | |
| 7 | 2015 | 250 | |
| 8 | 2019 | 186 | |
| 9 | 2013 | 170 | |
| 10 | 2013 | 149 | |
| 11 | 2013 | 85 | |
| 12 | 2013 | 85 | |
| 13 | 2014 | 75 | |
| 14 | 2013 | 54 | |
| 15 | 1998 | 52 | |
| 16 | 2010 | 50 | |
| 17 | Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues. | 2003 | 40 |
| 18 | 2000 | 35 | |
| 19 | 2013 | 34 | |
| 20 | 2020 | 33 |
About Victor A. Sandor
Victor A. Sandor is a scholar working on Genetics, Hematology, Oncology, Molecular Biology and Dermatology, having authored 45 papers that have together received 6.6k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Chronic Myeloid Leukemia Treatments (9 papers), Melanoma and MAPK Pathways (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Multiple Myeloma Research and Treatments (3 papers), Kruppel-like factors research (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Genetics (2.2k citations), Hematology (1.5k citations), Oncology (2.4k citations), Rheumatology (708 citations) and Molecular Biology (3.1k citations). Victor A. Sandor has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Susan E. Bates, Robert W. Robey, Richard Piekarz, Susan Bakke, Paolo A. Ascierto, Reinhard Dummer, Michael D. Pickard, Caroline Dutriaux, Ana Maria Arance and Helen J Gogas. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Lancet Oncology, New England Journal of Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.